EMFO LLC’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$462K Hold
3,366
0.41% 50
2024
Q1
$462K Hold
3,366
0.42% 52
2023
Q4
$457K Sell
3,366
-770
-19% -$93.9K 0.42% 53
2023
Q3
$506K Hold
4,136
0.48% 50
2023
Q2
$525K Sell
4,136
-1,000
-19% -$130K 0.48% 48
2023
Q1
$663K Hold
5,136
0.63% 45
2022
Q4
$674K Sell
5,136
-430
-8% -$55.6K 0.68% 42
2022
Q3
$651K Hold
5,566
0.62% 46
2022
Q2
$655K Buy
5,566
+620
+13% +$73.6K 0.67% 42
2022
Q1
$644K Sell
4,946
-120
-2% -$15.6K 0.58% 44
2021
Q4
$773K Hold
5,066
0.68% 37
2021
Q3
$819K Sell
5,066
-170
-3% -$28.6K 0.72% 35
2021
Q2
$857K Buy
+5,236
New +$807K 0.75% 37

Other funds holding IBB

EMFO LLC's IBB Position: Q2 2024 in Review

EMFO LLC held its iShares Biotechnology ETF (IBB) position steady in Q2 2024 at 3,366 shares worth $462K. The position accounts for 0.41% of the portfolio, ranked #50.

EMFO LLC first reported a position in IBB in Q2 2021 and has held it in 13 quarters since. The position peaked at $857K in Q2 2021. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

  • EMFO LLC held 3,366 shares of iShares Biotechnology ETF worth $462K as of Q2 2024.
  • EMFO LLC left its iShares Biotechnology ETF share count unchanged in Q2 2024.
  • iShares Biotechnology ETF made up 0.41% of EMFO LLC's portfolio in Q2 2024, its #50 holding.
  • EMFO LLC first reported a position in iShares Biotechnology ETF in Q2 2021 and has held it in 13 quarters since.
  • EMFO LLC's iShares Biotechnology ETF position peaked at $857K in Q2 2021.
  • 894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on EMFO LLC's 13F filing for Q2 2024, filed 26 Jul 2024.